European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478- ((full))

The European Pharmacopoeia (Ph. Eur.) Monograph 0478 is the foundational quality standard for tablets intended for oral administration in Europe. Published by the European Directorate for the Quality of Medicines & HealthCare (EDQM), it establishes legally binding requirements for the definition, production, and testing of diverse tablet forms to ensure patient safety and therapeutic efficacy. 1. Scope and Definition

The Ph. Eur. monograph for Tablets - 0478 plays a crucial role in ensuring the quality of tablet formulations. By following the guidelines set out in the monograph, manufacturers can ensure that their tablets meet the required standards for quality, purity, and strength. Regulatory authorities and control laboratories also use the monograph to evaluate the quality of tablets. European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-

2.2. Types Covered

• Uncoated tablets
• Film-coated tablets
• Sugar-coated tablets

• In modern QbD (Quality by Design), dissolution is superior to disintegration for predicting in vivo performance. The monograph still allows disintegration as a surrogate, which can be misleading for poorly soluble drugs.

• For immediate-release tablets: Dissolution test (2.9.3) is the default, unless the monograph specifies Disintegration (2.9.1). This aligns with the biopharmaceutics classification system philosophy.
• Provides clear acceptance criteria (Q value – typically 75-80% dissolved in a specified time).

Whether you are a formulation scientist or a quality control specialist, understanding this monograph is essential for ensuring every batch meets rigorous safety and efficacy benchmarks. What is Monograph 0478? Monograph 0478, titled simply Tablets (Compressi) The European Pharmacopoeia (Ph

: This test determines whether tablets break down within a specified time when placed in a liquid medium, ensuring the drug will be available for absorption. Subdivision of Tablets (Break-marks) In modern QbD (Quality by Design), dissolution is

The European Pharmacopoeia (Ph. Eur.) monograph for Tablets (0478) provides a comprehensive set of specifications for the testing and evaluation of tablets. The monograph covers a range of requirements, including appearance, average weight, uniformity of weight, hardness, friability, disintegration, and dissolution. By following these specifications, manufacturers can ensure that their tablets meet the necessary standards for quality, purity, and strength.

• Appropriate primary/secondary packaging to maintain product quality; label must state batch number, expiry, storage conditions, and dosing instructions.